Celltrion, Foreign Investors Net Sell 46,952 Shares... Stock Price -1.85%
As of 10:30 AM on the 15th, Celltrion is trading at 318,000 KRW, down 1.85% from the previous day. This represents a 10.61% increase compared to June 18. Celltrion is known as a protein and biopharmaceutical manufacturing company.
Today, foreigners have net sold 46,952 shares of Celltrion, while institutions have net bought 10,000 shares, according to provisional data. Over the past five days, individual investors have net bought 95,845 shares, whereas foreigners and institutions have net sold 67,787 shares and 55,608 shares, respectively.
On July 10, Celltrion was in the spotlight in the market for "rising due to a contract for contract manufacturing of a migraine treatment worth 115.6 billion KRW."


※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
Hot Picks Today
"Samsung and Hynix Were Once for the Underachievers"... Hyundai Motor Employee's Lament
- Samsung Enterprise Labor Union: "We Respect Court’s Injunction Decision... General Strike to Proceed on the 21st as Planned"
- "Was This Delicious Treat Enjoyed Only by Koreans?"... The K-Dessert Captivating Japan
- First Unification White Paper Under Lee Administration: 'Denuclearization and Human Rights' Greatly Reduced, Focus on 'Peaceful Exchange First'
- "That? It's Already Stashed" Nightlife Scene Crosses the Line [ChwiYak Nation] ③
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.